ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease
ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease
Recruiting · NCT03671889 · Registry updated 2026-01-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease | Alzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Recruiting | Not applicable | 2026-01-09 | NCT03671889 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| InSightec | 28 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Advent Health | Orlando | United States | 2 |
| Baptist Health South Florida & Florida International University | Miami | United States | 1 |
| Broward Health Medical Center & The University of Florida | Fort Lauderdale | United States | 1 |
| Delray Medical Center & Florida Atlantic University | Delray Beach | United States | 1 |
| Tampa General Hospital | Tampa | United States | 2 |
| The Ohio State University -Wexner Medical Center | Columbus | United States | 1 |
| University of Florida Health Shands | Gainesville | United States | 1 |
| University of Texas Southwestern Medical Center | Dallas | United States | 249 |
| Weill Cornell Medicine | New York | United States | 122 |
| West Virginia University Rockefeller Neuroscience Center | Morgantown | United States | 1 |